Weight Loss
Sculptra, hyaluronic filler regimen corrects facial sagging from GLP-1-induced weight loss
New data suggest Restylane Lyft or Contour in combination with Sculptra corrects contour deficiencies in patients experiencing facial volume loss following medication-driven weight loss, according to a Galderma press release.
GLP-1s reduce weight, with investigational therapies potentially more effective
A dozen GLP-1 receptor agonists and coagonists demonstrated effectiveness for weight loss in adults with obesity and without diabetes, a systematic review published in Annals of Internal Medicine showed.
Novel drug confers weight loss of up to 20% at 1 year in phase 2 study
Maridebart cafraglutide, a novel injectable GLP-1 receptor agonist/GIP receptor antagonist, reduced body weight by up to approximately 20% at 1 year in patients with overweight or obesity without a weight loss plateau, according to a presentation.
Cardiometabolic benefits of time-restricted eating may go beyond weight loss
The health benefits of time-restricted eating go beyond weight loss and may be most prominent in patients already with cardiometabolic syndrome at baseline, a speaker reported.
Racial, ethnic minorities less likely to use weight loss medications to manage obesity
Use of weight loss medications appeared to be significantly lower among those from certain racial and ethnic minority groups, results from a cross-sectional study published in Journal of Racial and Ethnic Health Disparities revealed.
Sarcopenia unlikely for most after weight loss, but more data needed on older adults
Most adults who lose weight as part of obesity therapy should not experience sarcopenia due to a decrease in fat-free mass, but more research is needed on the impact of GLP-1 receptor agonists and similar drugs on older adults.
Adherence to anti-obesity drugs, engagement with behavioral programs key to weight loss
SAN ANTONIO — Adherence to anti-obesity medications and engagement in intensive behavioral programs are key to higher sustained and categorical weight loss, according to findings from analyses presented at ObesityWeek.
Gestational weight loss may increase perinatal risks for women with obesity
Gestational weight loss may increase risks for adverse perinatal outcomes for women in all obesity classes, with the prevalence increasing with obesity severity, according to cohort study results published in Obesity.
Novel GLP-1 analog utreglutide confers weight loss, improves leptin resistance
SAN ANTONIO — Utreglutide, a novel GLP-1 analog, when administered in multiple ascending doses, demonstrated sustained weight loss for weeks after discontinuation among otherwise healthy men with overweight or obesity, a speaker reported.
Novel GLP-1 analog injection reduced weight for Chinese adults with overweight, obesity
SAN ANTONIO — For Chinese adults with overweight or obesity, GLP-1 analog injections were safe and well tolerated, demonstrating robust body weight reductions and improved cardiometabolic parameters, researchers reported.